awmsg logo



cefuroxime (Aprokam®)


Reference No. 2224

Publication date:
08/08/2017


Appraisal information

cefuroxime (Aprokam®) 50 mg powder for solution for injection


Company: Thea Pharamaceuticals Ltd.
BNF category: Eye
NMG meeting date: 07/06/2017
AWMSG meeting date: 19/07/2017
   
   
Submission Type: Limited Submission
Status: Recommended
Advice No: 1417
Ministerial ratification: 07/08/2017

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Cefuroxime (Aprokam®) is recommended as an option for use within NHS Wales for the antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download